MeCo Score: A Novel Biomarker for Predicting Response to Antifibrotic Therapy in Breast Cancer

A multinational study published in the journal *Cancers* reveals that the MeCo Score, a novel biomarker, quantifies mechanical conditioning in breast ...
Home/KnloSights/Clinical Trial Updates/MeCo Score: A Novel Biomarker for Predicting Response to Antifibrotic Therapy in Breast Cancer